Health Law360 provides breaking legal news and analysis on the health care industry. Coverage includes litigation, policy developments, and corporate deals involving health care services companies such as hospitals, health insurers, physicians groups, and medical suppliers.

Sign up for a 7-day FREE trial today!

Latest News in Health

• February 26, 2026

  H-1B $100K Fee Fight Is On, But Tariff Ruling's Effect Is Unclear

  A California federal judge on Thursday denied the Trump administration's request to pause a suit by employers challenging President Donald Trump's $100,000 H-1B visa fee, but he held off on deciding the employers' preliminary injunction request and ordered the parties to brief whether the U.S. Supreme Court's recent ruling on tariffs affects the case.

• February 26, 2026

  Domestic Violence Groups Fight Bondi Over Grant DEI Rules

  U.S. Attorney General Pam Bondi and 17 domestic violence coalitions are fighting in Rhode Island federal court over the groups' bid for a temporary restraining order to block the government from cutting off grant funds that don't comply with President Donald Trump's diversity, equity and inclusion rules.

• February 26, 2026

  IRhythm Investors Say 2021 Goldman Ruling Doesn't Bar Cert.

  IRhythm Technologies investors urged a California federal judge Thursday to certify a class that bought 30 million shares while the digital healthcare company allegedly jacked its stock price with false and misleading statements about a heart-event monitoring device, saying the U.S. Supreme Court's 2021 Goldman price impact ruling doesn't apply.

• February 26, 2026

  Doximity Investors' $31M Deal Over User Slowdown OK'd

  Investors of medical professional networking platform Doximity Inc. scored preliminary approval of a $31 million class settlement in California federal court Wednesday, two years after suing Doximity for allegedly misleading them about the number of U.S. physicians who are active members and hiding unfavorable engagement metrics.

• February 26, 2026

  Health Plans Lack Expert In Avandia MDL, 3rd Circ. Told

  Counsel for GlaxoSmithKline urged a Third Circuit panel on Thursday to undo an order certifying a class of health plans in the multidistrict litigation over the company's alleged deceptive marketing of the diabetes drug Avandia, arguing the plaintiffs didn't have the experts necessary to support their case.

See more Health news